Author Interviews, NEJM, Neurology, Pain Research / 18.08.2021
Episodic Migraine: Atogepant Effective At Reducing Migraine Days
MedicalResearch.com Interview with:
[caption id="attachment_57964" align="alignleft" width="200"] Dr. Ailani[/caption]
Jessica Ailani M.D. FAHS FAAN FANA
Director Medstar Georgetown Headache Center
Vice Co-Chair of Strategic Planning for MedStar Neurology
Professor of Clinical Neurology
MedStar Georgetown University Hospital
MedicalResearch.com: What is the background for this study?
Response: Migraine is a common neurological disease that causes disabling attacks that can be frequent. Preventive treatments can help reduce the frequency of attacks and improve patient function, reducing disease burden.
Dr. Ailani[/caption]
Jessica Ailani M.D. FAHS FAAN FANA
Director Medstar Georgetown Headache Center
Vice Co-Chair of Strategic Planning for MedStar Neurology
Professor of Clinical Neurology
MedStar Georgetown University Hospital
MedicalResearch.com: What is the background for this study?
Response: Migraine is a common neurological disease that causes disabling attacks that can be frequent. Preventive treatments can help reduce the frequency of attacks and improve patient function, reducing disease burden.